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Abstract
Background: This study investigated the prevalence of wheezing, asthma, and eczema among Australian children
using longitudinal data from birth to 15 years of age. This study also examined the association between maternal
health status during pregnancy and their offspring’s respiratory and allergic morbidities using sex-segregated data.
Methods: This study used data from the Longitudinal Study of Australian Children (LSAC) where approximately
5000 children of a birth cohort across Australia were surveyed in 2004. These children were followed biennially in
eight waves up to their age of 15 years until 2018. The status of the children’s wheezing, asthma, and eczema were
reported by the mothers upon doctors’ diagnosis (for asthma) or self-assessment (for wheezing or eczema).
Binomial logistic regression models were used to analyse associations between maternal health during pregnancy
and their children’s health outcomes.
Results: Asthma prevalence among 0–1-year aged children was 11.7%, increased to 15.4% when the children were
10–11 years old, and then decreased to 13.6% when they were 14–15 years old. Wheezing and eczema were most
prevalent when the children were 2–3 years old (26.0 and 17.8% respectively) and were least prevalent when the
children were 14–15 years old (7.3 and 9.5% respectively). Maternal asthma, smoking during pregnancy, and pre-
pregnancy obesity were significantly associated with an increased risk of wheezing and asthma in Australian
children. Childhood eczema was associated only with maternal asthma. These associations were stronger among
male children up to age 10–11 and during adolescence (12–15 years of age), female children were more prone to
wheezing, asthma, and eczema.
Conclusion: This is a comprehensive longitudinal study of Australian children (0–15 years of age) to assess the
prevalence (with sex-specific differences) of wheezing, asthma and eczema as well as the association between
these respiratory and allergic morbidities and maternal health during pregnancy. The study findings suggest that
careful medical and obstetric monitoring, improved specific age-sex wise risk factor prevention for children and
health promotion for pregnant women would help protect child health.
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Background
Childhood respiratory and allergic diseases, wheezing,
asthma, and eczema, are leading causes of global morbid-
ity [1]. The 2000–2003 International Study of Asthma and
Allergies in Childhood found that 14.1 and 7.3% of chil-
dren aged 13–14 years were currently suffering from
asthma or eczema, respectively [1]. The 2018 Australian
health survey revealed that among children aged 5–14
years, 11% reported current asthma, making asthma the
leading health burden in that age group [2]. A longitudinal
study conducted in 2009 found that 16.9% of Australian
children, born in 2004, experienced wheezing or asthma
within the first 3 years of life [3]. Wheezing, asthma and
eczema [4] pose significant long-term health burdens to
children, such as poor lung function or development of
persistent asthma in later life [5–8]. Furthermore, the inci-
dences of wheezing, asthma or eczema are influenced by
maternal health and environmental conditions [9–11]
which include maternal exposures to asthma, obesity, anti-
biotic/antidepressant medication use or smoking during
pregnancy [4, 8, 12–16]. Therefore, comprehensive re-
search related to longitudinal prevalence of wheezing,
asthma, and eczema among children, taking maternal
health during pregnancy into account, is a public health
priority.
As a definition, wheezing has been defined as a “con-
tinuous high-pitched sound with musical quality emit-
ting from the chest during expiration” and results in
“the narrowing of intrathoracic airways and expiratory
flow limitation” [17]. Some studies have shown that ap-
proximately 25% of children with persistent asthma had
wheezing symptoms in their early life [17–19]. The Glo-
bal Initiative for Asthma (GINA) states that “asthma is a
syndrome with a highly variable clinical spectrum, char-
acterised by airway inflammation” [17].
Asthma also causes shortness of breath and chest
tightness, and can cause cough [5]. The definition of ec-
zema is based on the Hanifin and Rajka validated criteria
[20], which include: itchy skin conditions in the past 12
months, history of skin creases, history of dry skin in the
past 12 months and visible flexural dermatitis. Though
there are several cross-sectional studies [21], the preva-
lence of each of these conditions (wheezing, asthma and
eczema) are understudied in contemporary population-
based longitudinal studies of children’s health.
Pregnancy is a crucial period in determining the future
health of the offspring [10] and hence, further under-
standing on mother’s pregnancy health and children’s re-
spiratory and allergic diseases are necessary. To date
several studies have shown that maternal asthma during
pregnancy, pre-pregnancy obesity, and gestational weight
gain are associated with an increased risk of asthma or
wheezing in the offspring [12, 22–24]. However, most of
these existing studies followed children from the first
year of life to preschool or early school age [12, 25].
There is little longitudinal information about associa-
tions between maternal health during pregnancy and
long-term respiratory or allergic health outcomes in chil-
dren through following the participants up from birth to
adolescence [8, 26].
A growing body of literature reveals that maternal risk
behaviours, such as smoking during pregnancy [27] and
maternal use of some medications [28, 29], are associated
with increased risk of wheezing or asthma in the offspring.
Although prenatal or postnatal smoking is a significant
risk factor for wheezing and asthma among infants and
preschool-age children [27, 30], it is not well known how
the number of cigarettes smoked during pregnancy effects
the association. Some studies have shown that maternal
use of medications, which includes paracetamol use [31]
or high doses of folic acid [29] during pregnancy had in-
fluenced health outcomes in children such as increased
risk of childhood asthma [14, 32]. However, few studies
have examined the effects of anti-depressant or antibiotic
medication use during pregnancy on childhood wheezing,
asthma or eczema [31, 33]. In Canada, the Manitoba prov-
ince population-based study from 1996 to 2012, revealed
that prenatal antibiotic exposure was associated with an
increased risk of asthma [33]. No population based com-
prehensive study examined the effects of anti-depressant
or antibiotic medication use during pregnancy on Austra-
lian children.
Sex dimorphism has long been recognised to childhood
morbidities, but few studies investigated the sex-specific
differences on children’s respiratory and allergic diseases
[34, 35]. For example, a 2003–2008 study in Greece
showed that male:female ratio of current and lifetime
wheezing and asthma increased; although, irrespective of
sex, asthma diagnosis declined among school-age children,
but not among preschool wheezers [34]. However, these
studies only focused on prevalence and lacked investiga-
tion on the sex-specific associations of familial heredity or
maternal health during pregnancy. Few studies have used
a single population-based prospective study on both re-
spiratory and allergic diseases [36, 37], or adjusted for
confounding factors of maternal health during pregnancy
to determine the age and sex-specific effects on children’s
respiratory and allergic diseases [14, 25]. Longitudinal
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investigation of sex differences of wheezing, asthma and
eczema in Australian children (birth to 15 years of age),
associated with maternal health during pregnancy, is
limited.
The present study, therefore, aims to determine the sex-
specific longitudinal prevalence of respiratory and allergic
diseases, wheezing, asthma, and eczema, among children
from birth to the age of 15 years on a population based
longitudinal data of Australian children. Further, it investi-
gates the association between maternal health or health
risk behaviours (asthma, gestational age, maternal pre-
pregnancy BMI, maternal smoking or use of antibiotics or
antidepressants) during pregnancy and the offspring’s
wheezing, asthma, and eczema throughout childhood (in-
cluding sex-disaggregated differences) to the age of 15
years. Findings of this study would broaden the under-
standing of the age and sex specific long-term aetiology of
childhood respiratory and allergic morbidities.
Methods
Data source and sample selection
The data was obtained from eight waves of the 2004–2018
Longitudinal Study of Australian Children (LSAC). LSAC
is a representative household survey of Australian children
that biennially collects information on the health (physical
and socio-emotional), and learning development of Aus-
tralian children based on the context of the bio-ecological
framework of human development [38]. The LSAC data is
collected from the parents or caregivers of the children of
participating households and from the children themselves
(from age 12 onward), through self-completed question-
naires or face-to-face interviews with trained interviewers.
A multi-stage sampling technique was used to select the
LSAC respondents. The household is the primary sam-
pling unit. Further details regarding LSAC survey design
and methodology can be found elsewhere [39].
The LSAC dataset contained information on children’s
wheezing, asthma, and eczema-related health and their
mothers’ self-reported health (asthma, pre-pregnancy
obesity) and health-risk behaviours (medications, smok-
ing habits) during pregnancy from the biological
mother-child pair as well as eight waves of the child’s
ongoing health up to 15 years of age.
After excluding children from non-biological parents,
the final sample was 4977 in Wave 1. There were drop-
outs in the subsequent waves and at Wave 8 the attrition
rate was 38.8% sustaining 2960 mothers and children in
the sample. An additional appendix file shows the total
LSAC participants, the attrition rates and the final study
sample after exclusion of non-mother parents for each
of the waves in Fig. A1 (see Additional file 1). This figure
also shows the loss to follow-up sample for Wave 2 to
Wave 8 calculated from eligible sample of the first wave
(baseline wave) to the particular wave.
Outcome variables
The outcome variables of this study were whether the
children: (i) had wheezing, (ii) were ever diagnosed with
asthma, (iii) had current asthma for which they took
medication, or (iv) had eczema. The LSAC survey re-
spondents’ (parents/caregivers) were asked the following
questions: (i) Has your child had an illness with wheez-
ing in the chest which lasted for a week or more in the
last 12 months?; (ii) Has a doctor ever told you that your
child has asthma?; (iii) Has your child taken any medica-
tion for asthma in last 12 months?; and (iv) Does your
child have any ongoing conditions with eczema? A bin-
ary variable was used to capture each of these responses
(Yes = 1 and No = 0).
Existing literature shows that although a good portion
of preschool children have wheezing, not all of them di-
agnosed with asthma when they reach school age [17,
19]. In LSAC, wheezing condition was monitored in
every wave, however, asthma was identified if the re-
spondents reported doctor diagnosed asthma and it was
started to trace first when the children reached 2–3 years
age. Hence, this study followed up both wheezing and
asthma separately, though many international multi-
country or national studies determined asthma preva-
lence by assessing presence of wheezing as a symptom
of asthma [5]. We took the opportunity to separately
identify wheezing and asthma of LSAC to increase the
specificity of these respiratory diseases among children
over time.
Independent variables
The independent variables considered in this study were
based on the existing literature on this topic [13, 23, 40,
41]. The following independent variables were used: (i)
incidence of asthma during pregnancy, (ii) mother’s pre-
pregnancy BMI, (iii) gestational age at birth, (iv) mater-
nal smoking during pregnancy, (v) the number of ciga-
rettes smoked by mother during pregnancy, and (vi) the
use of antibiotics or antidepressant medications taken by
mother during pregnancy.
The data for the variable maternal asthma come from
this question: ‘During the pregnancy with child, did
(you/child’s mother) take any medicines or tablets on a
doctor’s prescription for asthma?’. If a mother used any
medication for the treatment of asthma, then the re-
sponse was categorised as Yes =1; if not, it was cate-
gorised as No = 0. Maternal BMI was calculated from
their pre-pregnancy height and weight recorded in Wave
1. Mothers’ BMI was categorised into four groups ac-
cording to World Health Organization (WHO) guide-
lines: (i) ‘underweight’ (BMI < 18.50), (ii) ‘healthy weight’
(18.5 ≤ BMI < 25), (iii) ‘overweight’ (25 ≤ BMI < 30), and
(iv) 'obese' (BMI ≥ 30). Approximately 20% of respon-
dents did not provide height or weight; therefore, these
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mothers were grouped into a ‘not measured’ category.
The children’s gestational age was recorded in weeks
and categorised into three categories: (i) on time (37–41
weeks), (ii) early (36 weeks or less), (iii) or late (42 weeks
or more). Information on maternal smoking during
pregnancy was collected in Wave-1 of LSAC surveys. If
mothers smoked during their pregnancy, the number of
cigarettes smoked during the first trimester of pregnancy
was recorded in the study. From this record, this study
categorised data as follows: (i) none, (ii) < 10 daily, and
(iii) 11+ daily. The information on medication use dur-
ing pregnancy was also collected via mothers’ responses
to ‘What prescribed medicines or tablets were taken
during pregnancy?’. If mothers took any medications re-
lated with antibiotics or antidepressants, the responses
were coded with dichotomous values where ‘Yes’ = 1 and
‘No’ = 0 for each of these two types of medications.
Control variables
Based on existing literature [3, 13, 14, 32], this study con-
sidered the following confounding variables. Socio-
demographic covariates included were (i) age of the
mother (<=18, 19–34, > = 35 years), (ii) gender of the child
(male or female), (iii) whether English is spoken at home
(yes or no), (iv) whether mother is married with a partner,
with a de facto partner, or single, (vi) indigenous status
(yes or no), (vii) education of the mother (year 12 or less,
professional qualification, graduate diploma, or postgradu-
ate), (viii) family income (five quantiles), and (ix) remote-
ness of the family residence (highly accessible, accessible/
moderately accessible, or remote/very remote). Other
health or health-behaviour related confounders considered
were (i) the type of birth (normal, caesarean, or other), (ii)
birthweight (<=2500 g or > 2500 g), (iii) the immunisation
status of the child (completely up to date or not), and (iv)
the mother’s quality of sleep in the year prior to childbirth
(very good/fairly good, fairly bad or very bad). The home
condition related one relevant confounder was (i) home
exterior condition (fair/well-kept exterior, bad/poor Exter-
ior or not sighted).
Statistical analysis
Descriptive statistics of the characteristics of the eight
LSAC waves of sampled children and mothers have been
presented using weighted frequency (n) and percentages
(%). Further, descriptive analysis of the characteristics of
the loss to follow-up samples on the outcome and ex-
planatory variables have been performed. We performed
this analysis to assess whether there were any bias on
the loss of the sampled subjects. Multivariate analyses of
binomial logistic regressions were employed to investi-
gate the associations between maternal asthma, maternal
obesity, gestation age, smoking and medication use (anti-
biotics or antidepressants) with the offspring’s risk of
exposure to childhood wheezing, asthma and eczema.
All of the maternal illness and health risk exposure vari-
ables were measured during the pregnancy, with the ex-
ception of obesity, for which the mothers reported their
pre-pregnancy height and weight. This study also inves-
tigated these associations with sex-segregated data. For
ease of interpretation, results of the multivariate analyses
of the binomial logistic regressions are presented in the
form of odds ratios (OR) with 95% confidence intervals
(CI). A p-value of 0.05 or lower was considered statisti-
cally significant. All statistical analyses were performed
using Stata (release 15) statistical software.
Loss to follow-up
Figure 1 showed the comparison of the prevalence of
wheezing, asthma and eczema among the children who
were lost in the follow-up wave compared to the whole
sample of that wave. The results of the analysis showed
minor differences in the prevalence of loss to follow-up
sample of each wave compared to the whole sample of
the that wave. Moreover, the trends of the prevalence
for each of the diseases were almost similar in the loss
to follow-up sample. In addition to Fig. 1, we have pre-
sented a detailed picture of this outcome variables’ ana-
lysis in Table A1 of Additional file 1. Further, we have
anlysed the frequency and percentages of the independ-
ent variables of this study on the loss to follow-up sam-
ple and it has been shown in Table A2 of the Additional
file 1. The baseline characteristics of the loss to follow-
up sample of each wave were similar to the characteris-
tics of whole baseline sample regarding the explanatory
variables. So, we may expect that there are no bias in the
estimates of the statistical models as we observed no bias
in the loss to follow-up samples over time.
Results
Prevalence of respiratory and allergic morbidities
The prevalence of wheezing among children in this study
in their first year of life was 16.5% and increased to 26.0%
when the children were aged 2–3 years (Fig. 2). However,
in every subsequent follow-up, there was a gradual de-
crease, and the prevalence of wheezing dropped to 7.3%
by the children’s 14-15th year. The prevalence of asthma
among children 2–3 years old was 11.7%. It increased to
15.3% between 6 and 10 years but then went down to
13.6% among adolescents aged 14–15 years. Prevalence of
current asthma was slightly higher among male children
up to the age of 12–13 years; however, increased preva-
lence was observed among female children aged 14–15
years. The prevalence of eczema was 14.7% among chil-
dren aged 0–1, and it decreased to 9.5% by the time chil-
dren reached adolescence. Eczema prevalence was higher
among male children until age 4–5 years but increased
among female children until it was 12.1% among females
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Fig. 1 The prevalence of wheezing, asthma and eczema among the children of loss to follow-up sample compared to the reference wave’s whole sample
Fig. 2 The percentage of Australian children, by age and sex, who (a) experienced wheezing in the last 12 months, (b) ever had diagnosed with
asthma, (c) experienced ongoing asthma, and (d) experienced eczema in the last 12 months. The values of data points are shown in an additional
appendix (see Additional file 2)
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aged 14–15 years, compared to 7.0% among males in the
same age group (Fig. 2).
Maternal health
In Wave 1, among the mothers, 7.2% had asthma during
their pregnancy, 14.4% were obese, and 15.1% smoked
during the pregnancy. Furthermore, 4.4% of mothers
smoked 11 cigarettes (or more) daily in their 1st trimes-
ter of pregnancy, 10.5% took antibiotic medication, and
2.1% took antidepressant medication during the preg-
nancy period (Table 1).
Association of maternal health during pregnancy with
offspring’s morbidities
Table 2 presents the associations between child wheez-
ing and maternal health (asthma, BMI), risk factors (ges-
tational age, smoking), and medication use (antibiotics,
antidepressants) during pregnancy. Children of mothers
who had asthma during pregnancy had an increased
odds (OR: 1.5–2.5) of having wheezing until age 12–13.
However, there was no significant association at the age
of 14–15. Table 3 represents the associations between
the above-mentioned maternal health and whether the
children were ever diagnosed with asthma (cumulative
effect). In all age groups at all the follow-ups, children’s
odds of having been diagnosed with asthma (by a doctor
or physician) were 2.5 times greater if their mother had
asthma during the pregnancy. In all follow-up groups,
the odds of experiencing current asthma were signifi-
cantly higher (OR: 2.5–3.7) among children whose
mothers had experienced asthma during their pregnancy
compared to the children of mothers who did not have
asthma (Table 4).
The odd of experiencing eczema was around 1.4 times
higher among the children 0–1 and 4–5 years of age
whose mother had experienced asthma in pregnancy com-
pared to the offspring of non-asthmatic mothers (Table 5);
this odds increased to 1.9 times when the children reached
6–7 years of age. However, from the age of 8–9 years until
adolescence, the influence of maternal asthma during
pregnancy on the odds of having eczema was insignificant
(Table 5). Interestingly, maternal asthma during preg-
nancy had a greater effect on the odds of the offspring
having asthma than on the odds of having eczema. This
was the pattern across all age groups.
The smoking status of mothers during pregnancy in-
fluenced their offspring’s health to varying extents across
the respiratory and allergic morbidities. Children of
mothers who smoked either less than 10 or 11 plus ciga-
rettes during pregnancy showed 1.52 to 2.61 times
greater odds to suffer from wheezing, although the odds
ratio decreased after the age of seven years (Table 2).
Children of mothers who smoked 11+ cigarettes a day
during the first trimester showed higher odds to have
ever been diagnosed with asthma (OR: 1.54–1.88) com-
pared to the children of non-smoking mothers during
pregnancy (Table 3). These children also showed higher
odds to have been currently experiencing asthma until
the age of 10–11 years (Table 4). However, maternal
smoking during pregnancy, with any number of ciga-
rettes, did not influence the odds of having eczema
among the children at any of age groups (Table 5).
Maternal pre-pregnancy obesity had an influence on
the offspring’s risk of experiencing wheezing and current
or past asthma but not eczema (Tables 2, 3, 4 and 5).
The odds of encountering wheezing illness was higher in
children aged 2–5 of overweight and obese mothers
compared to mothers of healthy weight, with odds ratio
ranging from 1.31 to 1.42 (Table 2). The odds ratio of
ever having been diagnosed with asthma ranged from
1.27 to 1.37 for children of overweight mothers and
from 1.39 to 1.45 for children of obese mothers com-
pared to the children of healthy weight mothers until
age 10–11 (Table 3). A similar trend was present in the
risk of currently having asthma among the children of
overweight and obese mothers (Table 4).
If the mothers had taken antibiotics or antidepressant
medication during pregnancy, their children showed
higher odds of being afflicted with wheezing between
ages 2 and 5 years than the children of mothers who did
not take these medications. However, maternal medica-
tion use showed no association with the risk of children
having asthma or eczema. Gestational age had a weak
association with wheezing among preschool-aged chil-
dren (0–5 years), but there was no association with
asthma or eczema among the children at any age.
Sex differences
This study also separately assessed the risks of and ma-
ternal associations with having respiratory or allergic
morbidities among male and female children across all
eight follow-ups. The statistical analyses were performed
with sex-segregated data for all the outcome variables of
this study with the same independent and control vari-
ables as shown in Table 2, 3 and 4. The detailed results
of this sex-segregated analysis have been shown in Add-
itional file 3. In Table 6, the compilation of odds of each
of the disease outcomes (wheezing, ever diagnosed with
asthma, ongoing asthma or eczema) of the children of
mothers exposed to asthma during pregnancy, compared
to the children of mothers who did not experience
asthma during pregnancy, have been shown for all chil-
dren and segregated by sex for the purpose of compari-
son. Up until the age of 10–11 years, male children had
higher odds to encounter these morbidities than their fe-
male counterparts. However, as adolescents (12–15 years
old), female children showed higher odds of having these
morbidities (wheezing, ever had asthma, ongoing asthma
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Table 1 Sample characteristics across the LSAC Waves
VARIABLES Age 0–1 Age 2–3 Age 4–5 Age 6–7 Age 8–9 Age 10–11 Age 12–13 Age 14–15
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
N 4977 4485 4264 4088 3922 3574 3097 2960
EXPOSURE VARIABLES
Mother had asthma during pregnancy
No 4619 (92.81) 4166 (92.89) 3960 (92.87) 3799 (92.93) 3633 (92.63) 3310 (92.61) 2862 (92.41) 2735 (92.40)
Yes 358 (7.19) 319 (7.11) 304 (7.13) 289 (7.07) 289 (7.37) 264 (7.39) 235 (7.59) 225 (7.60)
Pre-pregnancy Obesity of Mother
Underweight 469 (9.42) 429 (9.57) 403 (9.45) 385 (9.42) 367 (9.36) 339 (9.49) 283 (9.14) 271 (9.16)
Healthy weight 1786 (35.89) 1675 (37.35) 1617 (37.92) 1567 (38.33) 1516 (38.65) 1395 (39.03) 1249 (40.33) 1191 (40.24)
Overweight 1007 (20.23) 944 (21.05) 917 (21.51) 877 (21.45) 837 (21.34) 782 (21.88) 682 (22.02) 648 (21.89)
Obesity 714 (14.35) 674 (15.03) 642 (15.06) 619 (15.14) 602 (15.35) 550 (15.39) 483 (15.6) 459 (15.51)
Not measured 1001 (20.11) 763 (17.01) 685 (16.06) 640 (15.66) 600 (15.3) 508 (14.21) 400 (12.92) 391 (13.21)
Gestational age at birth
On time (37–41 weeks) 4407 (88.55) 3977 (88.67) 3786 (88.80) 3620 (88.54) 3492 (89.03) 3197 (89.46) 2782 (89.82) 2641 (89.22)
Early (36 weeks or less) 338 (6.80) 302 (6.73) 290 (6.80) 279 (6.83) 250 (6.37) 220 (6.15) 190 (6.13) 179 (6.04)
Late (42 weeks or more) 232 (4.65) 206 (4.60) 188 (4.40) 189 (4.63) 180 (4.60) 157 (4.39) 125 (4.04) 140 (4.74)
Mother ever smoked during pregnancy
No 4224 (84.88) 3797 (84.67) 3616 (84.81) 3451 (84.43) 3368 (85.87) 3063 (85.72) 2655 (85.72) 2549 (86.11)
Yes 753 (15.12) 688 (15.33) 648 (15.19) 637 (15.57) 554 (14.13) 511 (14.28) 442 (14.28) 411 (13.89)
Mother’s smoking during 1st trimester
None 4347 (87.35) 3906 (87.08) 3724 (87.33) 3560 (87.09) 3463 (88.3) 3149 (88.11) 2721 (87.84) 2609 (88.13)
< =10 cigarettes daily 410 (8.23) 372 (8.29) 346 (8.11) 338 (8.26) 301 (7.68) 287 (8.03) 250 (8.09) 233 (7.86)
11+ cigarettes daily 220 (4.42) 207 (4.62) 194 (4.56) 190 (4.65) 157 (4.01) 138 (3.86) 126 (4.07) 119 (4.01)
Antidepressant medication during pregnancy
No 4870 (97.86) 4385 (97.78) 4170 (97.79) 3989 (97.59) 3840 (97.92) 3501 (97.97) 3033 (97.93) 2919 (98.63)
Yes 107 (2.14) 100 (2.22) 94 (2.21) 99 (2.41) 82 (2.08) 73 (2.03) 64 (2.07) 41 (1.37)
Antibiotic medication during pregnancy
No 4452 (89.46) 4009 (89.38) 3816 (89.5) 3658 (89.49) 3502 (89.28) 3202 (89.59) 2773 (89.53) 2642 (89.27)




Normal (2500–3999) 4071 (81.79) 3677 (81.99) 3490 (81.84) 3343 (81.78) 3198 (81.53) 2896 (81.02) 2510 (81.04) 2400 (81.08)
Low (< 2500) 279 (5.61) 237 (5.29) 245 (5.75) 237 (5.79) 202 (5.15) 192 (5.38) 168 (5.42) 156 (5.27)
High (> = 4000) 627 (12.59) 571 (12.73) 529 (12.41) 508 (12.43) 522 (13.32) 486 (13.61) 419 (13.54) 404 (13.65)
Immunisation status of children
Up to date 4516 (90.74) 4091 (91.21) 3885 (91.1) 3694 (90.36) 3557 (90.7) 3258 (91.16) 2841 (91.72) 2700 (91.21)
Not up to date 461 (9.26) 394 (8.79) 379 (8.9) 394 (9.64) 365 (9.3) 316 (8.84) 256 (8.28) 260 (8.79)
Breastfed children up to 6months
Yes 2328 (46.78) 2092 (46.65) 2008 (47.1) 1934 (47.31) 1891 (48.22) 1745 (48.83) 1551 (50.07) 1491 (50.39)
No 2649 (53.22) 2393 (53.35) 2256 (52.9) 2154 (52.69) 2031 (51.78) 1829 (51.17) 1546 (49.93) 1469 (49.61)
Mother’s sleep quality in the year of childbirth
Very good/Fairly good 3478 (69.89) 3127 (69.72) 2966 (69.56) 2844 (69.57) 2736 (69.77) 2484 (69.5) 2149 (69.39) 2047 (69.16)
Fairly bad 1118 (22.46) 1000 (22.3) 961 (22.53) 921 (22.53) 899 (22.91) 817 (22.85) 715 (23.08) 685 (23.13)
Very bad 381 (7.66) 358 (7.98) 337 (7.91) 323 (7.9) 287 (7.32) 273 (7.65) 233 (7.53) 228 (7.71)
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or eczema) if their mother had asthma during
pregnancy.
Discussion
This study comprehensively investigated the prevalence
of respiratory and allergic morbidities (wheezing,
asthma, and eczema) among children (birth to adoles-
cence) and their association with maternal health factors
and exposures during pregnancy (asthma, smoking,
medication use, and pre-pregnancy obesity) using the
LSAC data. The longitudinal prevalence of asthma in
children aged 0–15 years of age measured in the eight
biennial LSAC surveys (2004–2018) was 2–4 percentage
points higher than the prevalence (11%) measured by
the national health survey of Australian children aged
5–14 in 2018 [2].
Consistent with earlier studies [12, 14, 23, 27, 40, 42],
this study also found that maternal asthma during preg-
nancy, smoking during pregnancy, and pre-pregnancy
obesity were significantly associated with increased risks
of wheezing and asthma among Australian children.
Childhood eczema was associated only with maternal
asthma during pregnancy and not with pre-pregnancy
obesity, smoking during pregnancy, or antibiotic/anti-
depressant medication use during pregnancy. These
findings are consistent with a Swedish study that con-
cluded that maternal BMI was associated with an in-
creased risk of asthma, but not with eczema or
sensitisation in offspring [13].
This study found that children’s risk of having ever
been diagnosed with asthma was positively associated
with maternal asthma during pregnancy. This associ-
ation was consistent and increased up to the age of 12–
13 years. Among the children whose mothers had been
experiencing asthma during pregnancy, the odds of hav-
ing been diagnosed with asthma and the odds of having
ongoing asthma were higher than the odds of having
wheezing or eczema and consistently increased until the
age of 10–11 years. A Danish study from a cohort of
675,379 singleton births (1996–2006) showed that chil-
dren of mothers who had severe asthma during preg-
nancy had a higher prevalence of asthma (OR: 1.37; 95%
CI: 1.17–1.61) compared with children of mothers with
mild or no asthma during pregnancy [40]. Thus, this
study reiterates previous findings of an association of
maternal asthma during pregnancy with the risk of the
offspring having asthma, but it also contributes further
insight into the trend of asthma morbidity risks across
age groups (birth to 15 years of age) among Australian
children.
Children of mothers who were overweight or obese
just before their pregnancy were highly likely to have at
some point, been diagnosed with asthma. However, this
likelihood diminished when they reached age 12 years.
These findings corroborate earlier studies, one of which
showed that United States children of obese mothers
were 1.63 times more likely to have asthma than those
of mothers with a healthy weight [23]. Though studies
have revealed that gestational age and birth weight influ-
ence the risk of having asthma in early childhood [26],
our study did not show any association with these con-
founding variables. These findings may imply a relation-
ship between childhood obesity and asthma exposure
among children but further research is needed [26, 43].
The adverse effects of smoking during pregnancy on
childhood asthma are already evident in the existing lit-
erature [44]. Children may suffer from asthma morbid-
ities due to exposure to environmental tobacco smoke
or parental prenatal/postnatal smoking [42]. Although
the rate of maternal cigarette smoking during pregnancy
has decreased in the last decade in Australia [4], the evi-
dence of the influence of smoking during pregnancy on
childhood asthma persists [45]. However, few studies
have investigated the number of cigarettes smoked dur-
ing pregnancy and its effects on respiratory and allergic
morbidities in their children [27]. This study investigated
the influence of maternal smoking during pregnancy ac-
cording to the category of number of cigarettes smoked.
The prevalence of wheezing was higher among the chil-
dren of mothers who smoked 11 or more cigarettes daily
and was lower among the children of mothers who
smoked fewer than ten cigarettes daily than the children
of mothers who did not smoke during their pregnancy.
The risk of asthma was only higher among the children
of mothers who had 11 or more cigarettes daily during
the first trimester of the pregnancy. Similarly, a Finish
study (children born in 1987) found that mothers’ smok-
ing, < 10 cigarettes per day or 11+ cigarettes per day
during pregnancy, increased the probability of their off-
spring’s asthma [27].
Research on the association between maternal anti-
biotic or antidepressant use during pregnancy and re-
spiratory and allergic morbidities in offspring is rare.
Two studies found that maternal use of antibiotics in
the third trimester of pregnancy, slightly increased the
risk of their preschool-aged children having asthma [15,
33]. A Danish study of a birth cohort by Stockhome
et al. [28] also found a causal effect but did not identify
any trimester-specific effects of antibiotic use. In our
study, except for wheezing among children of 2–5 years
of age, no significant associations were observed between
maternal medication use (antibiotics or antidepressants)
during pregnancy and increased the risk of their off-
spring’s respiratory or allergic morbidities. Further, our
findings corroborate with previous research on the use
of modern antidepressants during pregnancy [16] which
concluded that antidepressant use during pregnancy
generally does not increase asthma risk. However, a
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study by Liu et al. of the Danish children, revealed that
the use of an earlier variant of antidepressants during
pregnancy [16] was associated with an increased risk of
asthma among their offspring.
Our results indicate that maternal asthma during preg-
nancy increases the risk of children experiencing ec-
zema, although in our sample, the prevalence of eczema
was intermittent across the years until their adolescence.
Significant risk of exposure was evident when the chil-
dren were infants, aged 4–7 years, and again during
adolescence at 10–13 years of age. However, these asso-
ciations were not as strong as the children’s risk of en-
countering wheezing or asthma. A key finding of this
study is that among the maternal health conditions dur-
ing pregnancy, except for maternal asthma, none were
associated with the risk of their children having eczema.
The age at onset of wheezing, asthma or eczema shows
a pattern in our study with increasing prevalence in early
childhood and decreasing prevalence during adolescents.
Along with the maternal health risk factors revealed by
our study, several other environmental risk factors show-
ing association with these diseases revealed by other
studies might be useful to explain the prevalence pattern
[46, 47]. For example, a study demonstrates that early
life sensitization to indoor allergens or mould is a pre-
dictor of asthma development [46]. Further, another
study shows evidence that the indoor school environ-
ment is a significant reservoir of allergens, moulds, pol-
lutants, and endotoxin and that there is an association
between school exposure and pediatric asthma morbidity
[47]. Previous studies also show that early childhood
asthma is more common in children who are exposed to
soot, exhaust, household tobacco smoking by household
members, or oil smoke [48, 49]. Other studies have con-
cluded that nylon clothing, unfamiliar pets, dust, and
sweat are responsible for childhood eczema [50, 51]. All
of these studies revealing the risk factors of influencing
asthma or eczema are among the children in their early
childhood, which are in line with the results of our
study. Further, genetic influence on the age at onset of
asthma may also explain the prevalence pattern or the
association of risk factors of asthma. A study on Danish
twins by Thomsen et al. in 2010 reveals that the risk of
asthma in the co-twin decreases with increasing age at
onset of asthma in the index twin [52]. Another biomet-
ric analysis study by Skadhauge et al. emphasized a
major influence of genetic factors in the aetiology of
asthma. However, a substantial part of the variation in li-
ability to asthma is due to the impact of environmental
factors specific to the individual. The study found no
evidence for a substantial impact of genetic dominance
or the shared environment [53].
Our study findings support gender dimorphism for
both prevalence and risk factor associations of the
respiratory and allergic diseases. As evidence of the gen-
der differences, this study found that for both asthma
and eczema boys had increased prevalence compared to
girls in their early childhood, while it was reversed dur-
ing their adolescence. Further, regarding the odds of
having these diseases our study found that children
whose mothers had asthma during pregnancy, boys had
higher odds of having wheezing or asthma than girls
until age 10–11 years. However, in the adolescent age
group (12–15 years), the girls had higher odds of being
ill with ongoing asthma compared to the boys. These
study finding are supported by previous two studies con-
ducted on asthma and puberty [54]. Findings of other
studies also support a gender dimorphism in the obes-
ity–asthma phenotype; they have found that the odds of
asthma impairment related to obesity is highest among
women aged 12 to 44 years of age [55, 56]. The gender
differences may have been potentially linked to fluctua-
tions of hormones during puberty and menstruation
[54], physical activity levels, and eating habits [35].
These variations may also occur due to the differences
in gender-specific responses to immunological, environ-
mental, or occupational exposures [57–60].
A main strength of our study is its use of a large, na-
tionally representative, ethnically inclusive, population-
based birth cohort generalisable to all Australian chil-
dren born in 2004. A range of maternal health indica-
tors, including maternal asthma, pre-pregnancy obesity,
gestational age, antibiotic use, and antidepressant use,
were considered key explanatory variables. Adjustments
were made for important confounders such as the chil-
dren’s birth weight, breastfeeding status, housing envir-
onment and other socioeconomic covariates.
There are some limitations. First, the pre-pregnancy
BMI was calculated using self-reported data on height
and weight. Second, we did not have information about
the severity of maternal asthma, genetic factors, or envir-
onmental exposures such as maternal mental health dur-
ing pregnancy, infections during pregnancy, and
maternal or child exposure to air pollutants. Thus,
though we accounted for as many potential confounders
as possible, our analyses were limited by the measure-
ments available in the LSAC data. Future research could
include other such factors that may exacerbate or miti-
gate the effects of maternal asthma, smoking, and other
health status during pregnancy on their children’s re-
spiratory or allergic outcomes.
Conclusion
This longitudinal study revealed the prevalence trends of
childhood wheezing, asthma, and eczema at 0–15 year of
age and found increasing trend in early childhood and
decreasing trend from 6 to 7 years to until their age of
14–15 years. Wheezing decreased to a greater extent
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than asthma and eczema. There were gender differences
in the prevalence of these respiratory and allergic mor-
bidities over time. This study also found that maternal
asthma, obesity, and smoking during pregnancy were
significantly associated with an increased risk of off-
spring’s wheezing or asthma. Only maternal asthma dur-
ing pregnancy was significantly associated with the risk
of eczema of their offspring. There were age and sex
specific differences in the associations of maternal health
or health risk factors with disease outcomes: a shift in
the extent of the associations started at 6–7 years of age;
where, at this age point, higher odds of both asthma and
eczema were observed in female children. These findings
have important public health implications for Australia.
Our findings suggest that careful medical and obstetric
monitoring, improved specific age-sex wise risk factor
prevention where wheezing, asthma and eczema effect
children and health promotion for pregnant women and
children by the policy makers are highly warranted and
may help protect child health.
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